Toyama Chemical Licenses RA Drug to Turkish Firm

October 14, 2015
Toyama Chemical, a unit of Fujifilm Group, said on October 13 that it has agreed to grant Turkey’s TR-Pharm exclusive rights to develop, manufacture, and market its rheumatoid arthritis drug iguratimod in Turkey, the Middle East, and North Africa. Toyama...read more